Prognostic Factors in Malignant Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: A Baseline Risk Score

被引：0
|
作者：
Guijosa, A. [1 ]
Munoz-Montano, W. [1 ]
Trejo-Rosales, R. [2 ]
Gomez-Garcia, A. P. [1 ]
Cabrera-Miranda, L. A. [1 ]
Flores, D. [1 ]
Arrieta, O. [1 ]
机构：
[1] Natl Canc Inst Mexico INCan, Mexico City, DF, Mexico
[2] Natl Med Ctr, Century XXI, IMSS, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Mesothelioma; Prognosis; Chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.14A.02
引用
收藏
页码：S684 / S684
页数：1
相关论文
共 50 条
  • [31] Prognostic Biomarkers for Malignant Pleural Mesothelioma Treated with Chemotherapy
    Akgun, Hakan
    Metintas, Selma
    Ak, Guntulu
    Demirkol, Secil
    Aydin, Resat
    Isbilen, Murat
    Gure, Ali
    Metintas, Muzaffer
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1369 - S1369
  • [32] Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy
    Daitoku, Nobuya
    Miyamoto, Yuji
    Tokunaga, Ryuma
    Sakamoto, Yuki
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Iwagami, Shiro
    Yoshida, Naoya
    Baba, Hideo
    ANTICANCER RESEARCH, 2018, 38 (08) : 4883 - 4888
  • [33] Pleural fluid findings as prognostic factors for malignant pleural mesothelioma
    Gonlugur, Tanseli Efeoglu
    Gonlugur, Ugur
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2008, 22 (05) : 334 - 336
  • [34] Prognostic Factors and Predictive Model in Patients With Advanced Biliary Tract Adenocarcinoma Receiving First-Line Palliative Chemotherapy
    Park, Inkeun
    Lee, Jae-Lyun
    Ryu, Min-Hee
    Kim, Tae-Won
    Lee, Sung Sook
    Park, Do Hyun
    Lee, Sang Soo
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    CANCER, 2009, 115 (18) : 4148 - 4155
  • [35] First-line Nivolumab/Ipilimumab in patients with unresectable malignant pleural Mesothelioma (MPM): West of Scotland experience
    Qaisar, Aitzaz
    White, Mark
    Steele, Nicola
    LUNG CANCER, 2024, 190
  • [36] Pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment for Egyptian patients with malignant pleural mesothelioma
    Alorabi, M. O.
    El Wakil, H. M.
    El-Mahdy, M. M.
    Salem, D. A.
    Essa, A. E.
    Gaballah, A. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 752 - 752
  • [37] Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study
    Katirtzoglou, Nikolaos
    Gkiozos, Ioannis
    Makrilia, Nektaria
    Tsaroucha, Emilia
    Rapti, Aggeliki
    Stratakos, Grigorios
    Fountzilas, Georgios
    Syrigos, Konstantinos N.
    CLINICAL LUNG CANCER, 2010, 11 (01) : 30 - 35
  • [38] Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma
    Yeap, Beow Y.
    De Rienzo, Assunta
    Gill, Ritu R.
    Oster, Michela E.
    Dao, Mary N.
    Dao, Nhien T.
    Levy, Rachel D.
    Vermilya, Kimberly
    Gustafson, Corinne E.
    Ovsak, Gavin
    Richards, William G.
    Bueno, Raphael
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (11) : 1925 - 1935
  • [39] A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy
    Filippi, Roberto
    Montagnani, Francesco
    Lombardi, Pasquale
    Fornaro, Lorenzo
    Aprile, Giuseppe
    Casadei-Gardini, Andrea
    Faloppi, Luca
    Palloni, Andrea
    Satolli, Maria Antonietta
    Scartozzi, Mario
    Citarella, Fabrizio
    Lutrino, Stefania Eufemia
    Vivaldi, Caterina
    Silvestris, Nicola
    Rovesti, Giulia
    Rimini, Margherita
    Aglietta, Massimo
    Brandi, Giovanni
    Leone, Francesco
    ACTA ONCOLOGICA, 2021, 60 (10) : 1317 - 1324
  • [40] PROGNOSTIC FACTORS IN DIFFUSE MALIGNANT PLEURAL MESOTHELIOMA - A STUDY OF 167 PATIENTS
    CHAILLEUX, E
    DABOUIS, G
    PIOCHE, D
    DELAJARTRE, M
    DELAJARTRE, AY
    REMBEAUX, A
    GERMAUD, P
    CHEST, 1988, 93 (01) : 159 - 162
12345